Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
Albertsen
Peter C
PC
D000368:Aged; D001918:Brachytherapy / Q000009:adverse effects* / Q000379:methods; D015331:Cohort Studies; D007172:Erectile Dysfunction / Q000453:epidemiology / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011788:Quality of Life; D011832:Radiation Injuries / Q000175:diagnosis* / Q000453:epidemiology; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D012007:Rectum / Q000528:radiation effects; D012189:Retrospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D013997:Time Factors; D014549:Urinary Incontinence / Q000453:epidemiology / Q000209:etiology
D007457:Iodine Radioisotopes